Study on ASTRA TECH Implant System, Short Implants (OsseoSpeed™) Compared to Standard Length Implants (OsseoSpeed™) With Bone Substitution



Status:Active, not recruiting
Conditions:Dental
Therapuetic Areas:Dental / Maxillofacial Surgery
Healthy:No
Age Range:20 - 75
Updated:8/24/2017
Start Date:November 2009
End Date:November 2021

Use our guide to learn which trials are right for you!

Short Implants - An Alternative to Bone Grafting?

The study, with the ASTRA TECH Implant System, is comparing short implants (OsseoSpeed™) to
standard length implants (OsseoSpeed™) with bone substitution.

The hypothesis is that the use of short implants in posterior maxilla with inadequate bone is
as safe and predictable as placing standard length implants in combination with bone
augmentation.


Inclusion Criteria:

- Provision of informed consent

- Aged 20-75 years at enrolment

- History of edentulism in the study area of at least four months

- In need for 1-4 implants in either side of the posterior maxilla (premolar and molar
region)

- Neighboring tooth/teeth to the planned implant/s must have natural root(s) or implant
supported restoration, with absence of pathology or excessive bone loss, as judged by
the investigator

- Presence of natural tooth/teeth, partial prosthesis and/or implants in the opposite
jaw in contact with the planned crown/s

- Deemed by the investigator to have a bone height between 5 and 7 mm and a bone width
of a minimum of 6 mm

- Deemed by the investigator as likely to present an initially stable implant situation

Exclusion Criteria:

- Unlikely to be able to comply with study procedures, as judged by the investigator

- Earlier bone graft procedures in the study area

- Uncontrolled pathologic processes in the oral cavity

- Known or suspected current malignancy

- History of radiation therapy in the head and neck region

- History of chemotherapy within 5 years prior to surgery

- Systemic or local disease or condition that could compromise post-operative healing
and/or osseointegration

- Uncontrolled diabetes mellitus

- Corticosteroids, iv bisphosphonates or any other medication that could influence
post-operative healing and/or osseointegration

- Smoking more than 10 cigarettes/day

- Bruxism

- Present alcohol and/or drug abuse

- Involvement in the planning and conduct of the study (applies to both Astra Tech staff
and staff at the study site)

- Previous enrolment in the present study

- Simultaneous participation in another clinical study
We found this trial at
2
sites